HMS
CSTL icon

Hanseatic Management Services’s Castle Biosciences CSTL Stock Holding History

Hanseatic Management Services’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.41K Hold
203
– – 0.01% 113
2024
Q3 		$5.79K Buy
+203
New +$5.17K 0.01% 106

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hanseatic Management Services's CSTL Position: Q4 2024 in Review

Hanseatic Management Services held its Castle Biosciences (CSTL) position steady in Q4 2024 at 203 shares worth $5.41K. The position accounts for 0.01% of the portfolio, ranked #113.

Hanseatic Management Services first reported a position in CSTL in Q3 2024 and has held it in 2 quarters since. The position peaked at $5.79K in Q3 2024. 197 funds tracked by Wall St. Rank hold CSTL as of Q4 2024.

  • Hanseatic Management Services held 203 shares of Castle Biosciences worth $5.41K as of Q4 2024.
  • Hanseatic Management Services left its Castle Biosciences share count unchanged in Q4 2024.
  • Castle Biosciences made up 0.01% of Hanseatic Management Services's portfolio in Q4 2024, its #113 holding.
  • Hanseatic Management Services first reported a position in Castle Biosciences in Q3 2024 and has held it in 2 quarters since.
  • Hanseatic Management Services's Castle Biosciences position peaked at $5.79K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.